NCT01942486

Brief Summary

The purpose of this study is to determine if a special coating, applied to the surface of glasses can reduce the frequency and severity of migraine headaches in children and adolescents. This study is being conducted by researchers at Primary Children's Medical Center, The John Moran Eye Center, and the University of Utah Department of Electrical Engineering. The investigators have determined that a specific frequency of light is particularly bothersome to migraine patients. The coating they've developed is designed to block this frequency of light. Very few treatments are approved for the treatment of childhood migraine. The investigators hope that these glasses will provide a safe way to improve headaches in children.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 14, 2013

Completed
3 months until next milestone

First Posted

Study publicly available on registry

September 16, 2013

Completed
4 months until next milestone

Study Start

First participant enrolled

January 1, 2014

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2018

Completed
2 years until next milestone

Results Posted

Study results publicly available

March 26, 2020

Completed
Last Updated

November 9, 2022

Status Verified

November 1, 2022

Enrollment Period

4.2 years

First QC Date

June 14, 2013

Results QC Date

April 12, 2019

Last Update Submit

November 6, 2022

Conditions

Keywords

migrainephotophobialight sensitivitymelanopsin cellsintrinsically photosensitive retinal ganglion cells

Outcome Measures

Primary Outcomes (1)

  • HIT-6 Score

    The HIT-6 (Headache Impact Test) is a validated measure of the impact of headache on activities of daily living, functional health and well-being. The minimum score is 36 and the maximum score is 78. The higher the score, the more your headaches are adversely affecting activities of daily living. Patients who score higher than 50 are encouraged to seek help from their physician.

    12 weeks

Study Arms (1)

Investigational Coating

EXPERIMENTAL
Device: Investigational Coating

Interventions

Investigational Coating

Eligibility Criteria

Age7 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Must be diagnosed with migraine with aura or migraine without aura
  • Must have at least 10 headache days per month

You may not qualify if:

  • Currently wearing a spectacle tint specifically prescribed for migraine or light sensitivity
  • Pregnant
  • Unwilling or unable in the judgment of the investigator to complete the study
  • Unavailable for any of the study visits
  • Light sensitive conditions: meningitis, iritis, blepharospasm, albinism
  • Degenerative diseases of the retina or optic nerve: diabetic retinopathy, ischemic optic neuropathy
  • Medications known to affect retinal or optic nerve function: hydroxychloroquine, chloroquine, ethambutol, amiodarone, erectile dysfunction drugs
  • Best corrected visual acuity less than 20/40 in either eye

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Moran Eye Center

Salt Lake City, Utah, 84132, United States

Location

MeSH Terms

Conditions

Migraine DisordersPhotophobia

Condition Hierarchy (Ancestors)

Headache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVision DisordersSensation DisordersNeurologic ManifestationsEye DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Bradley Katz
Organization
University of Utah

Study Officials

  • Bradley Katz, MD

    University of Utah

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D.

Study Record Dates

First Submitted

June 14, 2013

First Posted

September 16, 2013

Study Start

January 1, 2014

Primary Completion

April 1, 2018

Study Completion

April 1, 2018

Last Updated

November 9, 2022

Results First Posted

March 26, 2020

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations